Skip to main content
Log in

Elevated Serum Level of MicroRNA (miRNA)-200c and miRNA-371-5p in Children with Kawasaki Disease

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that regulate the expression of protein-coding genes. Recently, miRNA levels have been used as a novel non-invasive biomarker for the diagnosis of various diseases. We aimed to identify serum miRNAs elevated in patients with Kawasaki disease (KD) and to explore the potential biological function of identified candidate miRNAs. Serum specimens were collected from children with KD (n = 12) and healthy controls (n = 6). miRNA microarray assays were performed using the PANArray™ miRNA expression profiling kit (PANAGENE Co., Daejeon, Korea). We used TargetScan and the database for annotation, visualization, and integrated discovery program to obtain a list of enriched biological pathways targeted by miRNAs elevated in KD patients. As a result, miR-200c and miR-371-5p were significantly upregulated in the KD group compared with the control group (p = 0.032 in both). By using TargetScan, we obtained a list of 421 and 542 genes predicted to be targeted by miR-200c and miR-371, respectively, and these genes were significantly (p < 0.05) clustered in 17 and 3 pathways, respectively. Many of them are major pathways involved in inflammatory responses. The present data support the hypothesis that the inflammatory response is a crucial mechanism for pathogenesis of KD, and miRNAs might be the main regulators of this inflammatory response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Akagi T (2005) Interventions in Kawasaki disease. Pediatr Cardiol 26:206–212

    Article  CAS  PubMed  Google Scholar 

  2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

    Article  CAS  PubMed  Google Scholar 

  3. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Belair C, Darfeuille F, Staedel C (2009) Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect 15:806–812

    Article  CAS  PubMed  Google Scholar 

  5. Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J et al (2011) Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 6:e26971

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C et al (2002) Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 86:286–290

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006

    Article  CAS  PubMed  Google Scholar 

  8. Cortez MA, Calin GA (2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9:703–711

    Article  CAS  PubMed  Google Scholar 

  9. Cui L, Guo X, Qi Y, Qi X, Ge Y, Shi Z et al (2010) Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol 2010:425939

    PubMed Central  PubMed  Google Scholar 

  10. Cui L, Qi Y, Li H, Ge Y, Zhao K, Qi X et al (2011) Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One 6:e27071

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Esquela-Kerscher A, Slack FJ (2006) Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer 6:259–269

    Article  CAS  PubMed  Google Scholar 

  12. Fu Y, Yi Z, Wu X, Li J, Xu F (2011) Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 49:4246–4251

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Ghelani SJ, Sable C, Wiedermann BL, Spurney CF (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 33:1097–1103

    Article  PubMed  Google Scholar 

  14. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222

    CAS  PubMed  Google Scholar 

  15. Kim VN (2005) Small RNAs: classification, biogenesis, and function. Mol Cells 19:1–15

    Article  CAS  PubMed  Google Scholar 

  16. Laupland KB, Dele Davies H (1999) Epidemiology, etiology, and management of Kawasaki disease: state of the art. Pediatr Cardiol 20:177–183

    Article  CAS  PubMed  Google Scholar 

  17. Liu RY, Diao CF, Zhang Y, Wu N, Wan HY, Nong XY et al (2013) miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells. Cancer Lett 335:351–360

    Article  CAS  PubMed  Google Scholar 

  18. Loveday EK, Svinti V, Diederich S, Pasick J, Jean F (2012) Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection. J Virol 86:6109–6122

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G et al (2011) miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 18:1628–1639

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733

    Article  PubMed  Google Scholar 

  21. Othumpangat S, Walton C, Piedimonte G (2012) MicroRNA-221 modulates RSV replication in human bronchial epithelium by targeting NGF expression. PLoS One 7:e30030

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Shimizu C, Kim J, Stepanowsky P, Trinh C, Lau HD, Akers JC et al (2013) Differential expression of miR-145 in children with Kawasaki disease. PLoS One 8:e58159

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123–141

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Teraguchi M, Ogino H, Yoshimura K, Taniuchi S, Kino M, Okazaki H et al (2013) Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study. Pediatr Cardiol 34:959–963

    Article  PubMed  Google Scholar 

  25. Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79–85

    Article  PubMed Central  PubMed  Google Scholar 

  26. Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Diaz P, Lorenzo-Patino MJ, Haz M et al (2012) Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 10:186

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M et al (2009) MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4:e7405

    Article  PubMed Central  PubMed  Google Scholar 

  28. Wang C, Yang S, Sun G, Tang X, Lu S, Neyrolles O et al (2011) Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One 6:e25832

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX (2012) Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg 73:850–854

    Article  CAS  PubMed  Google Scholar 

  30. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L (2012) Serum microRNA signatures identified by Solexa sequencing predict sepsis patients’ mortality: a prospective observational study. PLoS One 7:e38885

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Wendlandt EB, Graff JW, Gioannini TL, McCaffrey AP, Wilson ME (2012) The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-kappaB activation. Innate Immun 18:846–855

    Article  PubMed Central  PubMed  Google Scholar 

  32. Zhu YK, Cheng N, Hu Y, Cen YZ (2012) The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV. Sheng Li Ke Xue Jin Zhan 43:251–256

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank Ji Hye Yoon from PANAGENE Co., Ltd for help with miRNA microarrays and excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sin Weon Yun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yun, K.W., Lee, J.Y., Yun, S.W. et al. Elevated Serum Level of MicroRNA (miRNA)-200c and miRNA-371-5p in Children with Kawasaki Disease. Pediatr Cardiol 35, 745–752 (2014). https://doi.org/10.1007/s00246-013-0846-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-013-0846-6

Keywords

Navigation